CoChat
Sign Up
Cited by 74

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial–mesenchymal transition in a sumoylation-regulated manner

Chandhoke, A S, Karve, K, Dadakhujaev, S, Netherton, S, Deng, L, Bonni, S·2016·Cell Death & Differentiation
DOI 10.1038/cdd.2015.152
Open this paper in CoChat — free account

Abstract

Epithelial-mesenchymal transition (EMT) is a fundamental cellular process in epithelial tissue development, and can be reactivated in cancer contributing to tumor invasiveness and metastasis. The cytokine transforming growth factor-β (TGFβ) is a key inducer of EMT, but the mechanisms that regulate TGFβ-induced EMT remain incompletely understood. Here, we report that knockdown of the ubiquitin ligase Smurf2 promotes the ability of TGFβ to induce EMT in a three-dimensional cell culture model of NMuMG mammary epithelial cells. In other studies, we identify Smurf2 as a target of the small ubiquitin like modifier (SUMO) pathway. We find that the SUMO-E2 conjugating enzyme Ubc9 and the SUMO E3 ligase PIAS3 associate with Smurf2 and promote its sumoylation at the distinct sites of Lysines 26 and 369. The sumoylation of Smurf2 enhances its ability to induce the degradation of the TGFβ receptor and thereby suppresses EMT in NMuMG cells. Collectively, our data reveal that Smurf2 acts in a sumoylation-regulated manner to suppress TGFβ-induced EMT. These findings have significant implications for our understanding of epithelial tissue development and cancer.

Overview

Integrity signals

Registry

Crossref · 10.1038/cdd.2015.152

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 77

  1. Kalluri R, Neilson EG . Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776–1784. · DOI
  2. Boyer AS, Ayerinskas II, Vincent EB, McKinney LA, Weeks DL, Runyan RB . TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev Biol 1999; 208: 530–545. · DOI
  3. Thiery JP . Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442–454. · DOI
  4. Jakowlew SB . Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 2006; 25: 435–457. · DOI
  5. Kang Y, Massague J . Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118: 277–279. · DOI
  6. Thiery JP, Acloque H, Huang RY, Nieto MA . Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871–890. · DOI · Paper page
  7. Rotin D, Kumar S . Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol 2009; 10: 398–409. · DOI
  8. Hershko A, Ciechanover A . The ubiquitin system. Annu Rev Biochem 1998; 67: 425–479. · DOI · Paper page
  9. Yang Q, Lin HY, Wang HX, Zhang H, Zhang X, Wang HM et al. Expression of Smad ubiquitin regulatory factor 2 (Smurf2) in rhesus monkey endometrium and placenta during early pregnancy. J Histochem Cytochem 2007; 55: 453–460. · DOI
  10. Cao S, Xiao L, Rao JN, Zou T, Liu L, Zhang D et al. Inhibition of Smurf2 translation by miR-322/503 modulates TGF-beta/Smad2 signaling and intestinal epithelial homeostasis. Mol Biol Cell 2014; 25: 1234–1243. · DOI
  11. Narimatsu M, Bose R, Pye M, Zhang L, Miller B, Ching P et al. Regulation of planar cell polarity by Smurf ubiquitin ligases. Cell 2009; 137: 295–307. · DOI
  12. Schwamborn JC, Khazaei MR, Puschel AW . The interaction of mPar3 with the ubiquitin ligase Smurf2 is required for the establishment of neuronal polarity. J Biol Chem 2007; 282: 35259–35268. · DOI
  13. Podos SD, Hanson KK, Wang YC, Ferguson EL . The DSmurf ubiquitin-protein ligase restricts BMP signaling spatially and temporally during Drosophila embryogenesis. Dev Cell 2001; 1: 567–578. · DOI
  14. Bonni S, Wang HR, Causing CG, Kavsak P, Stroschein SL, Luo K et al. TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 2001; 3: 587–595. · DOI
  15. Stroschein SL, Bonni S, Wrana JL, Luo K . Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev 2001; 15: 2822–2836. · DOI
  16. Tang Y, Liu Z, Zhao L, Clemens TL, Cao X . Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J Biol Chem 2008; 283: 23956–23963. · DOI
  17. Tang LY, Yamashita M, Coussens NP, Tang Y, Wang X, Li C et al. Ablation of Smurf2 reveals an inhibition in TGF-beta signalling through multiple mono-ubiquitination of Smad3. EMBO J 2011; 30: 4777–4789. · DOI
  18. Inoue Y, Imamura T . Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer Sci 2008; 99: 2107–2112. · DOI
  19. Fukunaga E, Inoue Y, Komiya S, Horiguchi K, Goto K, Saitoh M et al. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells. J Biol Chem 2008; 283: 35660–35667. · DOI
  20. Kim S, Jho EH . The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2). J Biol Chem 2010; 285: 36420–36426. · DOI
  21. Cai Y, Shen XZ, Zhou CH, Wang JY . Abnormal expression of Smurf2 during the process of rat liver fibrosis. Chin J Dig Dis 2006; 7: 237–245. · DOI
  22. Cai Y, Zhou CH, Fu D, Shen XZ . Overexpression of Smad ubiquitin regulatory factor 2 suppresses transforming growth factor-beta mediated liver fibrosis. J Dig Dis 2012; 13: 327–334. · DOI
  23. Lin X, Liang M, Feng XH . Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J Biol Chem 2000; 275: 36818–36822. · DOI
  24. Geiss-Friedlander R, Melchior F . Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007; 8: 947–956. · DOI
  25. Johnson ES . Protein modification by SUMO. Annu Rev Biochem 2004; 73: 355–382. · DOI
  26. Yeh ET . SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem 2009; 284: 8223–8227. · DOI
  27. Massague J . TGFbeta in cancer. Cell 2008; 134: 215–230. · DOI · Paper page
  28. Valdes F, Alvarez AM, Locascio A, Vega S, Herrera B, Fernandez M et al. The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Mol Cancer Res 2002; 1: 68–78.
  29. Derynck R, Akhurst RJ . Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 2007; 9: 1000–1004. · DOI
  30. Siegel PM, Massague J . Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003; 3: 807–821. · DOI
  31. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL . Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 2005; 307: 1603–1609. · DOI · Paper page
  32. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A . TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005; 16: 1987–2002. · DOI
  33. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL . Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 2003; 5: 410–421. · DOI
  34. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 2000; 6: 1365–1375. · DOI · Paper page
  35. Miettinen PJ, Ebner R, Lopez AR, Derynck R . TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994; 127 (6 Pt 2): 2021–2036. · DOI
  36. Peng SB, Yan L, Xia X, Watkins SA, Brooks HB, Beight D et al. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition. Biochemistry 2005; 44: 2293–2304. · DOI
  37. Debnath J, Brugge JS . Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005; 5: 675–688. · DOI
  38. Swamydas M, Eddy JM, Burg KJ, Dreau D . Matrix compositions and the development of breast acini and ducts in 3D cultures. In Vitro Cell Dev Biol Anim 2010; 46: 673–684. · DOI
  39. Ikeuchi Y, Dadakhujaev S, Chandhoke AS, Huynh MA, Oldenborg A, Ikeuchi M et al. TIF1gamma protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1. J Biol Chem 2014; 289: 25067–25078. · DOI
  40. Shaw KR, Wrobel CN, Brugge JS . Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis. J Mammary Gland Biol Neoplasia 2004; 9: 297–310. · DOI
  41. Godde NJ, Galea RC, Elsum IA, Humbert PO . Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions. J Mammary Gland Biol Neoplasia 2010; 15: 149–168. · DOI
  42. Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, Santos V et al. The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc 2009; 4: 1591–1613. · DOI · Paper page
  43. Wiesner S, Ogunjimi AA, Wang HR, Rotin D, Sicheri F, Wrana JL et al. Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. Cell 2007; 130: 651–662. · DOI
  44. Hsu YH, Sarker KP, Pot I, Chan A, Netherton SJ, Bonni S . Sumoylated SnoN represses transcription in a promoter-specific manner. J Biol Chem 2006; 281: 33008–33018. · DOI
  45. Matunis MJ, Coutavas E, Blobel G . A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 1996; 135 (6 Pt 1): 1457–1470. · DOI
  46. Suzuki T, Ichiyama A, Saitoh H, Kawakami T, Omata M, Chung CH et al. A new 30-kDa ubiquitin-related SUMO-1 hydrolase from bovine brain. J Biol Chem 1999; 274: 31131–31134. · DOI
  47. Pichler A, Gast A, Seeler JS, Dejean A, Melchior F . The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 2002; 108: 109–120. · DOI
  48. Gong L, Kamitani T, Fujise K, Caskey LS, Yeh ET . Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J Biol Chem 1997; 272: 28198–28201. · DOI
  49. Palvimo JJ . PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem Soc Trans 2007; 35 (Pt 6): 1405–1408. · DOI
  50. Kotaja N, Karvonen U, Janne OA, Palvimo JJ . PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol 2002; 22: 5222–5234. · DOI
  51. Hickey CM, Wilson NR, Hochstrasser M . Function and regulation of SUMO proteases. Nat Rev Mol Cell Biol 2012; 13: 755–766. · DOI
  52. Shi Y, Massague J . Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685–700. · DOI
  53. Zavadil J, Bottinger EP . TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005; 24: 5764–5774. · DOI
  54. Miyazono K . Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jp Acad Ser B Phys Biol Sci 2009; 85: 314–323. · DOI
  55. Ogunjimi AA, Briant DJ, Pece-Barbara N, Le Roy C, Di Guglielmo GM, Kavsak P et al. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol Cell 2005; 19: 297–308. · DOI
  56. Izzi L, Attisano L . Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation. Oncogene 2004; 23: 2071–2078. · DOI
  57. Galliher AJ, Schiemann WP . Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res 2006; 8: R42. · DOI
  58. Galliher AJ, Schiemann WP . Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 2007; 67: 3752–3758. · DOI
  59. Kwon A, Lee HL, Woo KM, Ryoo HM, Baek JH . SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion. Mol Cells 2013; 36: 548–555. · DOI
  60. Park SH, Jung EH, Kim GY, Kim BC, Lim JH, Woo CH . Itch E3 ubiquitin ligase positively regulates TGF-beta signaling to EMT via Smad7 ubiquitination. Mol Cell 2014; 38: 20–25. · DOI
  61. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE . TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 2008; 31: 918–924. · DOI
  62. Hong J, Zhou J, Fu J, He T, Qin J, Wang L et al. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res 2011; 71: 3980–3990. · DOI
  63. Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R . Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci USA 2001; 98: 974–979. · DOI
  64. Netherton SJ, Bonni S . Suppression of TGFbeta-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells. PLoS One 2010; 5: e13971. · DOI
  65. Kong Y, Cui H, Zhang H . Smurf2-mediated ubiquitination and degradation of Id1 regulates p16 expression during senescence. Aging Cell 2011; 10: 1038–1046. · DOI
  66. Yu YL, Chou RH, Shyu WC, Hsieh SC, Wu CS, Chiang SY et al. Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke. EMBO Mol Med 2013; 5: 531–547. · DOI
  67. Pot I, Patel S, Deng L, Chandhoke AS, Zhang C, Bonni A et al. Identification of a novel link between the protein kinase NDR1 and TGFbeta signaling in epithelial cells. PLoS One 2013; 8: e67178. · DOI
  68. Huynh MA, Ikeuchi Y, Netherton S, de la Torre-Ubieta L, Kanadia R, Stegmuller J et al. An isoform-specific SnoN1-FOXO1 repressor complex controls neuronal morphogenesis and positioning in the mammalian brain. Neuron 2011; 69: 930–944. · DOI
  69. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K . Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science 1999; 286: 771–774. · DOI
  70. Konishi Y, Stegmuller J, Matsuda T, Bonni S, Bonni A . Cdh1-APC controls axonal growth and patterning in the mammalian brain. Science 2004; 303: 1026–1030. · DOI
  71. Sarker KP, Wilson SM, Bonni S . SnoN is a cell type-specific mediator of transforming growth factor-beta responses. J Biol Chem 2005; 280: 13037–13046. · DOI
  72. Bernard DJ . Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone beta subunit in mouse gonadotrope cells. Mol Endocrinol 2004; 18: 606–623. · DOI
  73. Stegmuller J, Huynh MA, Yuan Z, Konishi Y, Bonni A . TGFbeta-Smad2 signaling regulates the Cdh1-APC/SnoN pathway of axonal morphogenesis. J Neurosci 2008; 28: 1961–1969. · DOI · Paper page
  74. Dadakhujaev S, Salazar-Arcila C, Netherton SJ, Chandhoke AS, Singla AK, Jirik FR et al. A novel role for the SUMO E3 ligase PIAS1 in cancer metastasis. Oncoscience 2014; 1: 229–240. · DOI
  75. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL . MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 1996; 87: 1215–1224. · DOI
  76. Abdollah S, Macias-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL . TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 1997; 272: 27678–27685. · DOI
  77. Eapen SA, Netherton SJ, Sarker KP, Deng L, Chan A, Riabowol K et al. Identification of a novel function for the chromatin remodeling protein ING2 in muscle differentiation. PLoS One 2012; 7: e40684. · DOI

Cited by

Sorted by citations

Metadata

Authors
Chandhoke, A. S., Karve, K., Dadakhujaev, S., Netherton, S., Deng, L., & Bonni, S.
Venue
Cell Death & Differentiation
Publisher
Springer Science and Business Media LLC
Published
2015-12-18
Volume
23
Issue
5
Pages
876-888
ISSN
  • 1350-9047
  • 1476-5403
DOI
10.1038/cdd.2015.152
Cited by
74
References
2
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review